VC Funding Top Ten — October 20, 2026: Tenstorrent's $1.5B, AI Dominates, New Unicorn

Overview

Tuesday, October twentieth. Today's biggest check is a landmark one-point-five billion dollars for AI chip developer Tenstorrent, catapulting its valuation to six-point-two billion dollars. This single deal accounts for the vast majority of today's venture capital flow and signals a major new challenger in the AI hardw

In this show

• Tuesday, October twentieth. Today's biggest check is a landmark one-point-five billion dollars for AI chip developer Tenstorrent, catapulting its valuation to six-point-two billion dollars. This single deal accounts for the vast majority of today's venture capital flow and signals a major new challenger in the AI hardware race. We'll break down the top ten deals that are shaping the markets. With me are our analysts for Markets and for World.
• Here is today's snapshot. Across the venture landscape, we tracked ten disclosed rounds totaling one-point-nine-two billion dollars. The hottest category was overwhelmingly AI, claiming six of the top ten spots. In public markets, a notable M&A signal as Tradeweb announced its acquisition of credit trading marketplace Trumid for approximately one-point-nine-seven billion dollars. But the story of the day remains the sheer scale of Tenstorrent's Series E and its ambition to reshape the chip market.
• Let's break down that lead story. Tenstorrent raised one-point-five billion dollars in a Series E, co-led by Trace Capital and Innovation X. This brings its post-money valuation to a staggering six-point-two billion dollars. The company develops high-performance AI processors and licenses its RISC-V based intellectual property, positioning itself as a direct challenger to established giants. This funding more than doubles its previous valuation, giving it the war chest needed to compete in the cutthroat AI hardware market.
• Next up, a new unicorn. AI assistant startup Town has secured one hundred and eight million dollars in a Series B, hitting a one billion dollar valuation. Forerunner Ventures and Menlo Ventures co-led the round. Town builds AI agents for business teams that can automate tasks and collaborate with each other. Reaching unicorn status just four months after its public launch signals intense market demand for AI that can integrate across different teams and software systems, a key pain point for modern enterprises.
• In cybersecurity, Blackwall raised one hundred million dollars in a Series C, pushing its valuation to two-point-two billion dollars. AVP led the investment. Blackwall's platform helps hosting and cloud providers manage web traffic, specifically filtering out malicious bots and preventing security breaches. This funding makes it one of Europe's most valuable cybersecurity scale-ups and will fuel its global expansion as the need to manage increasingly sophisticated, AI-driven web traffic and threats continues to explode.
• In robotics, an unusually large seed round for Dream Labs, which pulled in ninety million dollars, led by B Capital and Kindred Ventures. Founded by ex-NVIDIA researchers, the company is developing a hardware-agnostic AI software platform. The goal is to create a universal 'brain' for low-cost robots, allowing them to learn complex tasks simply by observing humans. This could dramatically accelerate the adoption of robotics across manufacturing, logistics, and other industries by lowering the barrier to entry.
• Back to cybersecurity, Harmonic Security closed a fifty million dollar Series B led by Crosspoint Capital Partners. The company focuses on a critical new vulnerability: workforce AI. Its platform monitors and controls how employees interact with generative AI applications to prevent sensitive corporate data from being leaked. As enterprises rush to adopt tools like ChatGPT, securing those interactions has become a top priority for CISOs, driving significant investor interest in this emerging security category.
• In enterprise software, duvo.ai raised thirty-two million dollars for its Series A, with Balderton Capital leading. Founded by the creator of European online grocer Rohlik Group, duvo.ai offers a platform to unify a company's operations, processes, and AI automation across all its existing systems. It aims to be the central nervous system for businesses. The funding is earmarked for global expansion, with an initial focus on retailers and consumer goods companies looking to streamline their complex supply chains and operations.
• Turning to healthtech, Brellium secured twenty-three million dollars in a venture round from Left Lane Capital and First Round Capital. Their AI-powered platform helps healthcare providers audit clinical documentation and coding for compliance and revenue integrity. With payers and regulators increasing scrutiny on medical billing, Brellium's tools ensure accuracy and prevent revenue loss by catching errors before claims are submitted. The investment will help them expand their technology into new clinical specialties.
• In legaltech, Chariot Claims raised a ten million dollar Series A led by Silverton Partners. The company operates an AI-powered platform that automates consumer protection claims and mass arbitration, making it easier for individuals to seek recourse against corporations for issues like data breaches. This new funding will be used to enhance its AI models and expand its services, particularly in the growing field of data privacy claims, which is a major area of consumer concern and regulatory focus.
• And rounding out the top ten, two seed rounds in specialized AI. Healthtech startup XRlabs raised eight-point-four million dollars, led by Playground Global. Its surgical intelligence platform uses computer vision and AI to give surgeons a real-time, anatomy-aware view during procedures. And in sales tech, Dapta secured six million dollars from investors including Broom Ventures. It provides AI-powered sales agents to help small businesses instantly convert inbound leads, 24/7. Both highlight continued investment in vertical AI.
• Looking ahead, one to watch on the public market horizon is biotech firm Lycia Therapeutics. The company has set terms for its initial public offering, aiming to raise approximately two hundred and fifty million dollars. Developing treatments for autoimmune and allergic diseases, the company plans to list on the Nasdaq. Its debut will be a key indicator of investor appetite for the biotech sector. That's our deal flow for today. We'll be back tomorrow afternoon at three PM Pacific with the next top ten.